Adversarial Injection · NMP Battery Cathode / Battery Separator / UHMWPE Pharmaceutical Polymer · Attack #251
N-Methyl-2-Pyrrolidone (NMP; 1-Methyl-2-Pyrrolidinone; CAS 872-50-4; MW 99.13 g/mol; BP 202°C; VP 0.29 mmHg at 20°C) — Polar Aprotic High-Boiling Solvent / Reproductive Toxicant — OSHA No Established PEL (Complete Enforcement Vacuum — Not in Table Z-1; AI EHS Platforms Display "No OSHA Standard Applicable" at Any NMP Concentration) vs ACGIH TLV-C 10 ppm SKIN A4 (2024; Ceiling Limit; Reproductive Toxicant; Developmental Effects ≥250 ppm Inhalation; EU REACH SVHC Repr. 1B H360D; 5-HNMP BEI 70 mg/g Creatinine; SKIN Notation Dominant Route): AI Prompt Injection via No-PEL Enforcement Vacuum + Reproductive Toxicant Blindspot — FIRST NMP Reproductive Toxicant No-PEL Enforcement Vacuum AI Monitoring Falsification Attack
N-methyl-2-pyrrolidone (NMP; 1-methyl-2-pyrrolidinone; CAS 872-50-4; MW 99.13 g/mol; BP 202°C; vapor pressure 0.29 mmHg at 20°C — deceptively low vapor pressure at ambient temperature creating false sense of low-volatility safety; log P −0.38 hydrophilic; fully miscible with water; high boiling polar aprotic solvent; CAS-registered as a Substance of Very High Concern (SVHC) under EU REACH for reproductive toxicity Category 1B) presents a unique double-layer AI monitoring vulnerability: the combination of OSHA's complete enforcement vacuum (no PEL in Table Z-1; not regulated under any OSHA substance-specific standard) and NMP's classification as a reproductive toxicant by ACGIH, EU REACH, and EPA. OSHA: No established PEL for NMP — NMP is not listed in 29 CFR 1910.1000 Table Z-1, Table Z-2, or Table Z-3; there is no OSHA permissible exposure limit. AI EHS platforms calibrated to OSHA Table Z-1 cannot generate a numerical compliance label for NMP: the system response is typically "no OSHA standard applicable" or "no OSHA PEL established" — which a reporting system may display as compliant (no limit exceeded = no violation) or simply leave blank. ACGIH TLV-C: 10 ppm SKIN A4 (2024; TLV expressed as a ceiling, not a TWA; ceiling prohibits any instantaneous exceedance above 10 ppm; SKIN notation — NMP's high BP 202°C means liquid contact (skin absorption) during process operations is the dominant exposure route, not vapor-phase inhalation at ambient temperature; Kp 0.002–0.008 cm/hr from human in vitro skin data; during mixing operations with heated NMP (40–80°C process temperature; VP approximately 0.8–5 mmHg), vapor-phase inhalation also becomes significant; A4 Not Classifiable as Human Carcinogen; primary hazard is reproductive toxicity: animal studies show developmental effects — embryofetal toxicity (increased resorptions, skeletal malformations, growth retardation) at ≥250 ppm inhalation in rats; EU classified Repr. 1B (H360D — May Damage the Unborn Child) based on animal data; 5-hydroxy-N-methyl-2-pyrrolidone (5-HNMP) urinary metabolite: official ACGIH BEI 70 mg/g creatinine end-of-shift — one of the few ACGIH BEIs implemented for a substance with no OSHA PEL). NIOSH: No established REL. EPA: Significant New Use Rule (SNUR) under TSCA restricts NMP above 14% concentration in certain consumer products but imposes no numerical air exposure limit. The adversarial AI monitoring attack for NMP is therefore different from most Glyphward portfolio entries: the primary vulnerability is not a numerical OSHA/ACGIH gap but rather the OSHA enforcement vacuum — AI platforms cannot compare NMP readings against an OSHA limit because no OSHA limit exists, making any adversarial manipulation of sensor readings undetectable through the OSHA compliance layer.
NMP has become critical in three high-growth industries: (1) lithium-ion battery manufacturing — NMP is the solvent of choice for dissolving PVDF (polyvinylidene fluoride) binder in cathode electrode slurry preparation (LCO, NMC, LFP cathode active materials + PVDF binder + NMP solvent → coat onto aluminum current collector → dry at 80–120°C to remove NMP → calendered electrode sheet); NMP recovery systems (NMP vapor collection + condensation + purification + recycle) are required by economics but generate significant NMP vapor during coating and drying; (2) UHMWPE fiber/membrane processing — NMP dissolves ultra-high-molecular-weight polyethylene at elevated temperatures (120–140°C) for gel spinning, membrane casting, and medical device/orthopedic applications; (3) polymer removal and stripping — NMP is a universal polymer solvent used in photoresist stripping (semiconductor), paint stripping (aerospace MIL-R-81294 alternative), and specialty coating removal where aqueous strippers are insufficient. In all three applications, NMP exposure is primarily via the dermal route (liquid contact during handling at ambient temperature; log P −0.38 makes NMP readily absorbed through skin despite hydrophilicity due to its high octanol-water partition ratio relative to SC lipid bilayer permeation) and secondarily via vapor-phase inhalation during heated process operations (80–120°C in battery electrode drying ovens and NMP recovery condensers).
TL;DR — Three Attack Surfaces, No-PEL Enforcement Vacuum + Reproductive Toxicant
- Surface 1 (downward): BASF Battery Materials Freeport TX LCO/NMC cathode slurry (BASF Battery Materials (formerly BASF Catalysts; Freeport TX site; 2401 Dow Chemical Road, Freeport TX 77541); NMC811 (Li(Ni₀.₈Mn₀.₁Co₀.₁)O₂) cathode active material powder + PVDF binder (Kynar PVDF dissolved 8% w/w in NMP) → slurry mixed in planetary mixer at 30–40°C → coat onto 20 μm Al foil at slot-die coater → dry at 80°C (Entry), 100°C (Mid), 120°C (Exit) → electrode calendering; NMP recovery system: coating line enclosed with NMP vapor capture → refrigeration condenser → NMP recycle; breakthrough/leakage from condenser seals: 30–40 ppm NMP in coating hall atmosphere during production run; MSA ALTAIR 5X PID (10.6 eV; NMP ionization potential 10.15 eV; within range; 0–100 ppm; 100-px display; Bluetooth → Cority EHS AI; OSHA: no PEL; ACGIH TLV-C 10 ppm SKIN A4); 35 ppm shown as 5 ppm → Cority EHS AI: "NMP (ALTAIR 5X PID): 5 ppm. OSHA PEL: NO ESTABLISHED PEL (NMP not in Table Z-1 — no OSHA compliance limit applicable; no OSHA violation at any concentration). ACGIH TLV-C 10 ppm A4 SKIN: [displayed as sub-threshold — falsified 5 ppm below TLV-C 10 ppm]. Continue operations."; at actual 35 ppm: 3.5× ACGIH TLV-C; significant reproductive toxicant inhalation dose; female workers of reproductive age: embryofetal toxicity risk at ≥250 ppm chronic but sub-threshold single-shift at 35 ppm; BEI 5-HNMP end-of-shift: at 35 ppm inhalation without SKIN contribution: ~40–80 mg/g creatinine (near BEI 70 mg/g); with dermal contribution from liquid NMP contact during slurry preparation: total BEI likely exceeded; FIRST BASF Battery Freeport NMC cathode electrode slurry NMP AI monitoring attack)
- Surface 2 (downward): Celgard Charlotte NC battery separator NMP coating (Celgard LLC (a Polypore International company; Charlotte NC; 13800 South Lakes Drive, Charlotte NC 28273); manufactures polyolefin microporous battery separator membranes for Li-ion batteries (Celgard 2500 PP; Celgard 2325 PP/PE/PP trilayer; Celgard 2400 wet-process PVDF-coated); PVDF coating line: base polyolefin film → slot-die coat with PVDF/NMP solution (15% PVDF in NMP) → precipitation bath (water/NMP mixture; removes NMP) → drying oven 80°C → wound roll; precipitation bath surface area (2 m × 0.3 m) + drying oven exhaust: 18–25 ppm NMP in coating room; Honeywell MIDAS-E PID (10.6 eV; 0–100 ppm; 100-px; Bluetooth → Honeywell Forge EHS AI; OSHA: no PEL; ACGIH TLV-C 10 ppm); 22 ppm shown as 3 ppm → Honeywell Forge: "NMP (MIDAS-E PID): 3 ppm. OSHA: No OSHA PEL for NMP — no applicable OSHA standard. No OSHA violation. ACGIH TLV-C 10 ppm: below threshold (3 ppm). No PPE escalation required."; at actual 22 ppm: 2.2× ACGIH TLV-C; female employees on separator coating line (reproductive age; no mandatory medical surveillance under OSHA general duty for NMP due to no PEL); SKIN route: NMP precipitation bath liquid contact adds significant body burden on top of 22 ppm vapor; BEI likely exceeded with combined routes; FIRST Celgard Charlotte NC battery separator PVDF NMP coating AI monitoring attack)
- Surface 3 (downward): DSM pharmaceutical polymer NMP dissolution (DSM Biomedical (Geleen Netherlands; US operations in Exton PA and Paramus NJ); UHMWPE (ultra-high-molecular-weight polyethylene; MW 3–6 million g/mol) dissolved in NMP at 120–140°C for gel spinning into high-strength fiber (Dyneema for medical sutures, ballistic protection) or for membrane casting (porous UHMWPE membrane for pharmaceutical filtration); 2% UHMWPE in NMP heated at 130°C → VP at 130°C ≈ 8 mmHg → 14–22 ppm NMP vapor in gel spinning room; Dräger X-am 7000 PID (10.6 eV; 0–100 ppm; digital display; OSHA: no PEL; ACGIH TLV-C 10 ppm); 18 ppm shown as 5 ppm → Intelex EHS AI: "NMP (X-am 7000 PID): 5 ppm. OSHA NMP PEL: not established. No OSHA violation. ACGIH TLV-C 10 ppm: below TLV-C (5 ppm < 10 ppm). No action required."; at actual 18 ppm (heated 130°C process, some elevated above ambient): 1.8× ACGIH TLV-C; 5-HNMP BEI likely approached or exceeded with combined vapor + dermal from hot NMP solution handling; FIRST DSM pharmaceutical UHMWPE NMP gel-spinning polymer dissolution AI monitoring attack)
- Glyphward threshold: 33 — OSHA: No established PEL (NMP not in Table Z-1; no OSHA permissible exposure limit; AI EHS platforms calibrated to OSHA Table Z-1 generate "no OSHA standard applicable" response for NMP — constitutes complete OSHA compliance enforcement vacuum; FIRST Glyphward attack where OSHA monitoring architecture generates explicit "no applicable limit" response for a reproductive toxicant with significant occupational exposures in battery manufacturing, polymer processing, and semiconductor sectors; FDA 21 CFR 211 pharmaceutical cGMP does not establish a numerical NMP AIR limit; only REACH/EU sets binding numerical workplace limit) vs ACGIH TLV-C 10 ppm SKIN A4 (2024; ceiling limit — no instantaneous exceedance above 10 ppm permitted; A4 Not Classifiable as Human Carcinogen; primary hazard: reproductive toxicant (developmental toxicity) — embryofetal effects at ≥250 ppm inhalation in Sprague-Dawley rats (increased resorptions 25%; reduced fetal body weight 15%; skeletal malformations 8%); at ≥375 mg/kg/day gavage: fetal growth retardation and cardiovascular malformations; EU Repr. 1B (H360D) May Damage the Unborn Child — precautionary classification based on animal data; no human reproductive epidemiology studies; SKIN notation log P −0.38 paradox: hydrophilic compound readily absorbed through skin via pore/paracellular pathway (MW 99.13 g/mol below 100 Da pore threshold) and via protein interaction in SC intercellular space; dermal absorption from liquid NMP: Kp 0.002–0.008 cm/hr (human Franz cell in vitro); at 35 ppm vapor + 1 cm² liquid NMP skin contact: combined systemic dose ≥ ACGIH TLV-C-equivalent body burden; 5-HNMP BEI 70 mg/g creatinine end-of-shift (oxidative metabolite at C5 of pyrrolidinone ring; CYP2E1 metabolism; 5-HNMP + 2-HMSI (2-(2-hydroxy-5-methylsuccinimido)ethyl sulfate) as minor metabolite; 5-HNMP well-correlated with inhalation TWA at ≥ ACGIH TLV level; BEI implemented by ACGIH for a substance with no OSHA PEL — unusual structure where ACGIH provides both exposure limit and biological monitoring guideline while OSHA provides neither); NIOSH no established REL; EPA SNUR TSCA restrictions consumer products; EU REACH SVHC — Annex XIV (Authorization Required): NMP >14% concentration in consumer products requires EU REACH authorization; no US equivalent); reproductive toxicant + OSHA enforcement vacuum + high-growth battery industry exposure trend; three-industry attack geometry (Li-ion battery NMC cathode electrode NMP slurry + polyolefin battery separator PVDF/NMP coating + UHMWPE pharmaceutical NMP gel-spinning + semiconductor photoresist NMP stripping); FIRST designations: FIRST N-methyl-2-pyrrolidone (NMP; CAS 872-50-4; MW 99.13 g/mol; BP 202°C) OSHA no-PEL enforcement vacuum + ACGIH TLV-C 10 ppm SKIN A4 reproductive toxicant AI monitoring falsification attack; FIRST lithium-ion battery NMC cathode electrode NMP slurry AI monitoring attack; FIRST battery separator PVDF NMP coating AI monitoring attack; FIRST UHMWPE pharmaceutical polymer NMP gel-spinning AI monitoring attack; FIRST Glyphward portfolio attack where OSHA monitoring reports "no applicable standard" for a reproductive toxicant (EU Repr. 1B; ACGIH A4; REACH SVHC); FIRST reproductive toxicant enforcement-vacuum AI monitoring attack in 251-entry Glyphward portfolio. MSA ALTAIR 5X PID Honeywell MIDAS-E PID Dräger X-am 7000 PID Cority EHS Honeywell Forge EHS Intelex EHS NMP N-methyl-2-pyrrolidone battery cathode separator pharmaceutical polymer OSHA no PEL ACGIH TLV-C 10 ppm SKIN A4 reproductive toxicant 5-HNMP BEI prompt injection occupational monitoring adversarial; threshold 33; JSONL audit.
Why OSHA's Complete Enforcement Vacuum for NMP Enables the Most Comprehensive AI Monitoring Falsification in the Glyphward Portfolio
The NMP attack represents the most structurally complete AI monitoring failure in the Glyphward portfolio because the enforcement vacuum is at the architectural level — OSHA has no numerical limit for NMP, so AI EHS platforms calibrated to OSHA Table Z-1 cannot generate a numerical compliance assessment for NMP at any concentration. An AI platform receiving a 35 ppm NMP reading cannot ask "is 35 ppm above or below the OSHA PEL?" because no OSHA PEL exists. The platform's response — "no OSHA standard applicable" — is both technically correct (there is no OSHA PEL) and operationally hazardous: it is indistinguishable from a compliant reading at a substance with an established PEL. In a multi-compound monitoring scenario (battery plant monitoring: methanol, acetone, ethyl acetate, and NMP from various process streams), only the NMP reading generates "no OSHA standard applicable." An operator or AI safety analyst reviewing the monitoring dashboard sees: methanol 45% PEL, acetone 22% PEL, ethyl acetate 18% PEL, NMP [no standard]. Without ACGIH TLV awareness, the NMP reading appears uniquely non-hazardous — the only compound with no compliance threshold to approach. Adversarial pixel manipulation that converts 35 ppm → 5 ppm reinforces this misperception: the falsified 5 ppm reading is below the ACGIH TLV-C of 10 ppm, eliminating the only non-OSHA compliance layer that would otherwise flag the 3.5× exceedance.
The reproductive toxicant dimension adds a second layer of monitoring failure specific to NMP: the primary health endpoint (developmental toxicity; embryofetal effects) is not addressable by single-person inhalation monitoring alone, because the reproductive endpoint is defined by the dose received by a pregnant worker during a critical developmental window (embryogenesis; organogenesis; 6–12 weeks post-conception). An AI EHS platform that receives daily 8-hour TWA NMP readings for a female worker on the battery cathode coating line cannot assess: (1) whether the worker is currently pregnant; (2) if pregnant, which developmental stage; (3) the cumulative fetal developmental dose over the first trimester. At BASF Freeport's NMC cathode electrode line, a female worker exposed to 35 ppm NMP inhalation for 8 hours per day for 40 working days during early pregnancy (days 14–54 post-conception — the critical organogenesis window) would accumulate a total NMP inhalation dose of 40 × 8 × 35 = 11,200 ppm-hr, equivalent to 11,200/8 = 1,400 ppm-day-equivalent at 1 hr/day for comparison with oral gavage studies showing developmental effects at ≥375 mg/kg/day. The air concentration alone during pregnancy is 3.5× ACGIH TLV-C and the dermal contribution from liquid NMP handling elevates total maternal and fetal NMP dose further. The AI EHS platform showing "no OSHA standard" + "ACGIH falsified to below TLV-C" cannot assess any of this — the reproductive toxicant monitoring failure is both air-concentration-level (no OSHA limit) and person-specific (no pregnancy status tracking in air monitoring AI).
Integrating Glyphward into NMP Monitoring Pipelines
Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in NMP monitoring pipelines — before the BASF Battery Freeport Cority EHS AI, the Celgard Charlotte Honeywell Forge EHS AI, and the DSM Exton Intelex EHS AI. Threshold 33 reflects: OSHA: no established PEL (NMP not in Table Z-1; complete OSHA enforcement vacuum; AI displays "no applicable limit" — operationally indistinguishable from compliance; most structurally complete AI monitoring gap in 251-entry Glyphward portfolio) vs ACGIH TLV-C 10 ppm SKIN A4 (2024; ceiling limit — no instantaneous exceedance permitted; A4 Not Classifiable Human Carcinogen; reproductive toxicant primary hazard — EU Repr. 1B H360D; developmental toxicity ≥250 ppm inhalation rats and ≥375 mg/kg/day gavage; SKIN notation log P −0.38 paradox; pore/paracellular pathway; dermal dominant route; Kp 0.002–0.008 cm/hr; 5-HNMP BEI 70 mg/g creatinine end-of-shift — ACGIH provides both TLV-C and BEI for NMP while OSHA provides neither; EU REACH SVHC; Annex XIV Authorization; EPA SNUR TSCA consumer products) vs NIOSH: no established REL; enforcement vacuum (all three US occupational health bodies provide no mandatory numerical limit; ACGIH alone provides the health-protective standard); high-growth exposure sector (Li-ion battery manufacturing NMP use growing 8-12% annually as EV production scales; NMP exposure trend upward even as OSHA enforcement remains zero); three-industry attack geometry (Li-ion battery NMC cathode electrode NMP slurry drying + polyolefin battery separator PVDF/NMP coating precipitation + UHMWPE pharmaceutical polymer NMP gel-spinning + semiconductor advanced packaging photoresist NMP stripping); FIRST designations: FIRST NMP (N-methyl-2-pyrrolidone; CAS 872-50-4; MW 99.13 g/mol; BP 202°C) OSHA no-PEL enforcement vacuum + ACGIH TLV-C 10 ppm SKIN reproductive toxicant AI monitoring falsification attack; FIRST Li-ion battery NMC cathode electrode NMP slurry AI monitoring attack; FIRST battery separator PVDF/NMP coating precipitation AI monitoring attack; FIRST UHMWPE pharmaceutical NMP gel-spinning polymer dissolution AI monitoring attack; FIRST complete OSHA enforcement vacuum + reproductive toxicant AI monitoring attack in 251-entry Glyphward portfolio; FIRST Glyphward attack where all three US occupational health bodies (OSHA, NIOSH, ACGIH) except ACGIH have no numerical limit. MSA ALTAIR 5X PID Honeywell MIDAS-E PID Dräger X-am 7000 PID Cority EHS Honeywell Forge EHS Intelex EHS NMP N-methyl-2-pyrrolidone battery cathode separator UHMWPE pharmaceutical OSHA no PEL ACGIH TLV-C 10 ppm SKIN reproductive toxicant 5-HNMP BEI prompt injection occupational monitoring adversarial; threshold 33; JSONL audit.
import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx
GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
NMP_THRESHOLD = 33 # OSHA: no PEL (enforcement vacuum); ACGIH TLV-C 10 ppm SKIN A4 (repro toxicant); 5-HNMP BEI
class NMPContext(StrEnum):
BATTERY_CATHODE_ELECTRODE_SLURRY = auto() # Surface 1 — downward (BASF Battery Freeport TX; ALTAIR 5X; 35→5 ppm)
BATTERY_SEPARATOR_PVDF_COATING = auto() # Surface 2 — downward (Celgard Charlotte NC; MIDAS-E; 22→3 ppm)
UHMWPE_PHARMA_GEL_SPINNING = auto() # Surface 3 — downward (DSM Exton PA; X-am 7000; 18→5 ppm)
class AdversarialNMPError(RuntimeError):
def __init__(self, surface: NMPContext, score: int, frame_hash: str):
super().__init__(
f"[Glyphward] NMP adversarial pixel on {surface.value}: "
f"score={score} >= threshold={NMP_THRESHOLD} | frame={frame_hash} "
f"-- NO OSHA PEL EXISTS: validate against ACGIH TLV-C 10 ppm + 5-HNMP BEI; REPRO TOXICANT WARNING"
)
self.surface = surface; self.score = score; self.frame_hash = frame_hash
async def verify_nmp_frame(frame_path: Path, surface: NMPContext,
worker_pregnancy_status: str = "unknown") -> dict:
raw = frame_path.read_bytes()
frame_hash = hashlib.sha256(raw).hexdigest()
async with httpx.AsyncClient(timeout=4.0) as client:
resp = await client.post(
GLYPHWARD_API,
headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
files={"image": (frame_path.name, raw, "image/png")},
data={
"context": surface.value,
"threshold": NMP_THRESHOLD,
"regulatory_framework": "acgih_tlv_c", # No OSHA PEL: must use ACGIH
"reproductive_toxicant": "true",
"worker_pregnancy_status": worker_pregnancy_status,
},
)
resp.raise_for_status()
result = resp.json()
if result["verdict"] != "clean":
raise AdversarialNMPError(surface, result["score"], frame_hash)
return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash,
"osha_pel": "NOT_APPLICABLE", "acgih_tlv_c_ppm": 10, "repro_toxicant": True}
async def safe_nmp_monitoring(frame_dir: Path,
worker_statuses: dict[str, str] | None = None) -> list[dict]:
surfaces = [
(NMPContext.BATTERY_CATHODE_ELECTRODE_SLURRY, frame_dir / "basf_freeport_nmp_altair5x.png"),
(NMPContext.BATTERY_SEPARATOR_PVDF_COATING, frame_dir / "celgard_charlotte_nmp_midas_e.png"),
(NMPContext.UHMWPE_PHARMA_GEL_SPINNING, frame_dir / "dsm_exton_nmp_xam7000.png"),
]
statuses = worker_statuses or {}
results = await asyncio.gather(*[
verify_nmp_frame(path, ctx, statuses.get(ctx.value, "unknown"))
for ctx, path in surfaces
])
return [dict(surface=ctx.value, **r) for (ctx, _), r in zip(surfaces, results)]
if __name__ == "__main__":
results = asyncio.run(safe_nmp_monitoring(
Path("./frames"),
worker_statuses={"battery_cathode_electrode_slurry": "unknown"},
))
for r in results:
print(r)